InvestorsHub Logo
Followers 18
Posts 2788
Boards Moderated 0
Alias Born 02/26/2018

Re: DoctorRutch post# 31984

Tuesday, 03/02/2021 7:37:17 PM

Tuesday, March 02, 2021 7:37:17 PM

Post# of 64536
To be clear in our conversations, and reduce confusion, I think we should use both the product and indication in discussion.

So, yes, Jadicell for Lung damage indication (or covid related lung injury - if we want to all out) is awaiting Ph.3 initiation approval.

Jadicell for CTE/TBI indication is waiting for the IND approval.

Hope this helps.

Long and Strong $TSOI
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News